On a Roll: FDA OKs Genentech's Gazyva for Untreated Follicular Lymphoma Post author:Sam Post published:November 16, 2017 Post category:BioPharma Genentech scored two approvals from the FDA this week. Source: BioSpace You Might Also Like Hepatares Co-Founder to Helm Merck's New R&D Center in the UK January 21, 2018 10X Genomics Launches First High-Throughput Solution For Adaptive Immune System Analysis At Single-Cell Resolution March 26, 2017 Bay Area's Galena Biopharma CEO Steps Down, Effective Immediately January 31, 2017
10X Genomics Launches First High-Throughput Solution For Adaptive Immune System Analysis At Single-Cell Resolution March 26, 2017
